Upregulation of Mitochondrial Uncoupling Protein-2 by the AMP-Activated Protein Kinase in Endothelial Cells Attenuates Oxidative Stress in Diabetes

OBJECTIVE-Recent evidence suggests that the AMP-activated protein kinase (AMPK) is an important therapeutic target, for diabetes. The present study was conducted to determine how AMPK activation suppressed tyrosine nitration of prostacyclin synthase in diabetes. RESEARCH DESIGN AND METHODS-Confluent human umbilical vein endothelial cells (HUVECs) or mice were treated with 5-amino-4-imidazole carboxamide riboside (AICAR) for the detection of AMPK phosphorylation and the expression of mitochondrial uncoupling protein (UCP)-2. RESULTS-Exposure of HUVECs to high glucose (30 mmol/l) increased superoxide anions (O-2(radical anion)) and prostacyclin synthase nitration. in addition, overexpression of constitutively active AMPK (Ad-CA-AMPK) or the addition of AICAR reduced both O-2(radical anion) and prostacyclin synthase nitration caused by high glucose, whereas adenoviral overexpression of dominant-negative, AMPK Mutants (Ad-DN-AMPK) enhanced the latter effects of high glucose. Exposure of HUVECs to either AICAR or metformin caused AMPK-dependent upregulation of both UCP-2 mRNA and UCP-2 protein. Furthermore, overexpression of UCP-2 significantly ablated both O-2(radical anion) and prostacyclin synthase nitration triggered by high glucose. Furthermore, overexpression of Ad-CA-AMPK increased, whereas overexpression of Ad-DN-AMPK inhibited AICAR-induced phosphorylation of p38 kinase at, Thr180/Tyr182. Inhibition of p38 kinase with SB239063, which had no effect on AICAR-induced AMPK-Thr172 phosphorylation, dose dependently suppressed AICAR-induced upregulation of UCP-2, suggesting that AMPK lies Upstream of p38 kinase. Finally, AICAR markedly increased UCP-2 expression and reduced both O-2(radical anion) and prostacyclin synthase nitration in diabetic wild-type mice but not, in their AMPK alpha 2-deficient counterparts in vivo. CONCLUSIONS-We conclude that AMPK activation increases UCP-2, resulting in the inhibition of both O-2(radical anion) and prostacyclin synthase nitration in diabetes. Diabetes 57:3222-3230, 2008